TSS
HTGM

Two Sigma Securities’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History

Two Sigma Securities’s Portfolio HTGM Stock Details HTGM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,806
Closed -$13K – 3477
2022
Q3 		$13K Sell
1,806
-2,982
-62% -$36.3K ﹤0.01% 2372
2022
Q2 		$59K Buy
+4,788
New +$44.9K ﹤0.01% 1830
2020
Q4 		– Sell
-126
Closed -$7K – 2040
2020
Q3 		$7K Buy
+126
New +$11.3K ﹤0.01% 1257
2019
Q3 		– Sell
-62
Closed -$18K – 2572
2019
Q2 		$18K Buy
+62
New +$25.9K ﹤0.01% 1960
2017
Q4 		– Sell
-183
Closed -$56K – 2089
2017
Q3 		$56K Buy
+183
New +$69.5K 0.01% 732
2017
Q2 		– Sell
-120
Closed -$150K – 1250
2017
Q1 		$150K Buy
+120
New +$57.8K 0.03% 707

Other funds holding HTGM

TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HWM
HighMark Wealth Management St. Paul, Minnesota $246M AUM 35.95% 1-Year Est. Return
AF
Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
TWA
TCI Wealth Advisors Tucson, Arizona $1.88B AUM 21.09% 1-Year Est. Return

Two Sigma Securities's HTGM Position: Q4 2022 in Review

Two Sigma Securities sold out of HTG Molecular Diagnostics, Inc. Common Stock (HTGM) in Q4 2022, closing a stake of 1,806 shares — an estimated $13K sold.

Two Sigma Securities first reported a position in HTGM in Q1 2017 and held it in 6 quarters. The position peaked at $150K in Q1 2017. 10 funds tracked by Wall St. Rank hold HTGM as of Q4 2022.

  • Two Sigma Securities reported no remaining HTG Molecular Diagnostics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Two Sigma Securities sold 1,806 HTG Molecular Diagnostics, Inc. Common Stock shares in Q4 2022, an estimated $13K.
  • Two Sigma Securities first reported a position in HTG Molecular Diagnostics, Inc. Common Stock in Q1 2017 and held it in 6 quarters.
  • Two Sigma Securities's HTG Molecular Diagnostics, Inc. Common Stock position peaked at $150K in Q1 2017.
  • 10 funds tracked by Wall St. Rank held HTG Molecular Diagnostics, Inc. Common Stock as of Q4 2022.

Based on Two Sigma Securities's 13F filing for Q4 2022, filed 14 Feb 2023.